Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protocolized Clonidine for Dexmedetomidine Withdrawal
NCT05575219Phase 4Completed
- Sponsor
- UTHealth Houston
- Start
- Oct 2022
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clonidine in Drug Withdrawal Syndrome, sponsored by UTHealth Houston. Started Oct 2022; status: completed.
02
Drugs
clonidine
03
Conditions
Drug Withdrawal Syndrome
Beyond the preview
Go deeper on NCT05575219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05575219.